Anti-inflammatory and immune response regulation of Si-Ni-San in 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin dysfunction

J Ethnopharmacol. 2018 Aug 10:222:1-10. doi: 10.1016/j.jep.2018.04.032. Epub 2018 Apr 24.

Abstract

Ethnopharmacological relevance: Si-Ni-San (SNS) is a well-known decoction in traditional Chinese medicine. Although studies have indicated that the anti-inflammatory and anti-allergic properties of SNS and its components can account for their therapeutic effects, the role and mechanism of SNS in treating skin dysfunction remain unclear.

Aim of the study: Atopic dermatitis (AD), a disorder known for its prevalence in infants and adults, severely influences the quality of life of affected patients. In this study, we aimed to investigate the anti-inflammatory and immune response modulations of SNS in 2,4-dinitrochlorobenzene (DNCB)-induced AD-like skin dysfunction.

Materials and methods: Dermatitis was induced in Kunming mice by the topical application of DNCB. SNS or dexamethasone (positive control) was topically applied every day over the course of the 21-day study. The following were assessed: dermatitis severity scores; ear and dorsal skin haematoxylin and eosin staining; interleukin (IL)- 1α, IL-1β, IL-2, IL-4, IL-6, and tumour necrosis factor (TNF)-α cytokine levels in the serum; spleen index; spleen CD4 + /CD8 + T lymphocyte ratio; and phosphorylation levels of mitogen-activated protein kinases (MAPKs- p38, extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK)), IκB-α, and nuclear factor (NF)-κB (p65) in skin lesions.

Results: SNS significantly alleviated the symptoms of AD-like lesions induced by DNCB, decreased the infiltration of inflammatory cells in the ear and dorsal tissues, suppressed the increased cytokine levels in the serum, reduced the CD4 + /CD8 +T lymphocyte ratio in the spleen, and downregulated the activation of MAPKs, IκB-α, and NF-κB (p65) in the dorsal skin. The effects were similar to those of dexamethasone.

Conclusions: SNS alleviated the DNCB-induced AD-like skin dysfunction in mice through anti-inflammatory and immune system modulation, indicating that SNS shows potential for AD treatment in clinical settings.

Keywords: Atopic dermatitis; Immune response; Inflammatory; Si-Ni-San.

MeSH terms

  • Animals
  • Anti-Allergic Agents / therapeutic use*
  • Anti-Inflammatory Agents / therapeutic use*
  • CD4-CD8 Ratio
  • Cytokines / blood
  • Dermatitis, Atopic / chemically induced
  • Dermatitis, Atopic / drug therapy
  • Dermatitis, Atopic / immunology
  • Dermatitis, Atopic / pathology
  • Dinitrochlorobenzene
  • Drugs, Chinese Herbal / therapeutic use*
  • Immunologic Factors / therapeutic use*
  • Male
  • Mice
  • Phytotherapy
  • Skin / drug effects
  • Skin / immunology
  • Skin / pathology
  • Spleen / drug effects
  • Spleen / immunology

Substances

  • Anti-Allergic Agents
  • Anti-Inflammatory Agents
  • Cytokines
  • Dinitrochlorobenzene
  • Drugs, Chinese Herbal
  • Immunologic Factors
  • shigyaku-san